Company Number: 12828722

Analysis Date: 2025-07-20 12:12 UTC

Financial Health Assessment for ATAVIST SUPPLEMENTS LTD

---

1. Financial Health Score: D

Explanation:
The company shows signs of financial distress with negative net current assets and total net assets (liabilities) for the latest year, indicating a fragile liquidity position and net liability status. Although the company is still operating with some assets, the erosion of shareholders’ funds and an ongoing net deficit reflect underlying financial stress. This score suggests caution and urgent attention to financial management.

---

2. Key Vital Signs

Metric	2024 (£)	Trend Since 2020	Interpretation
Fixed Assets	170	Stable	Very low fixed assets – minimal long-term investments.
Current Assets	50,940	Increased significantly (from 9,864)	Increase mainly in cash or receivables - potentially good liquidity if collectible.
Current Liabilities	84,395	Increased (from 37,229)	Significant rise in short-term debts – pressure on cash flow.
Net Current Assets (Working Capital)	-33,455	Declining from +27,365 to negative	Negative working capital indicates inability to cover short-term debts with current assets.
Total Net Assets (Equity)	-34,185	Declining from +28,095 to negative	The company is in a net liability position, indicating solvency concerns.
Share Capital	502	Stable	Nominal share capital – limited equity base.
Number of Employees	3	Stable	Small workforce consistent with micro company status.

Interpretation of Vital Signs:

• Negative Working Capital (Net Current Assets): The company’s current liabilities exceed current assets by £33k, a critical symptom of liquidity distress, meaning it may struggle to pay debts as they fall due.
• Net Liability Position: Total liabilities surpass total assets by £34k, indicating the company’s balance sheet is "underwater." This is a serious warning sign of insolvency risk if conditions persist.
• Increasing Current Liabilities: Almost doubling current liabilities from 2020 might indicate growing reliance on short-term creditors or suppliers, raising the risk of cash flow strain.
• Stable but minimal Fixed Assets and Share Capital: The company is asset-light and with a small equity base, making it vulnerable to shocks.

---

3. Diagnosis

ATAVIST SUPPLEMENTS LTD exhibits symptoms of financial distress primarily due to liquidity challenges and an eroding equity base. The negative working capital suggests the company does not have enough short-term assets to cover its immediate liabilities—a "cash flow blockage." This could be due to delayed customer payments, increased short-term borrowing, or accumulated trade creditors.

The negative net assets indicate that the company has accrued losses or liabilities exceeding its assets, raising solvency concerns. While the company remains active and has no overdue filings or liquidation status, this financial snapshot signals a health condition akin to a patient showing signs of chronic stress with compromised reserves. Without intervention, the risk of insolvency or forced restructuring grows.

The company operates in the retail sale of medical and orthopaedic goods (specialised stores), a sector sensitive to inventory management and timely payments. The increase in current assets is encouraging but overshadowed by rising liabilities, suggesting potential delays in converting assets to cash or over-reliance on credit.

---

4. Recommendations

To improve financial wellness and restore a healthy balance sheet, I recommend the following actions:

• Improve Liquidity Management:

  • Tighten credit control to accelerate receivables collection and reduce cash conversion cycle.
  • Negotiate longer payment terms with suppliers to ease current liabilities pressure.
  • Maintain a cash flow forecast to anticipate and manage short-term funding needs.

• Reduce Short-Term Debt Reliance:

  • Explore refinancing options to convert short-term liabilities into longer-term debt if possible.
  • Avoid additional short-term borrowing unless it improves cash flow sustainably.

• Cost Control and Operational Efficiency:

  • Review operational costs and overheads to identify savings without compromising sales capacity.
  • Optimize inventory levels to reduce tied-up capital in stock.

• Equity Injection or Capital Restructuring:

  • Consider bringing in new equity investment to shore up net assets and restore solvency.
  • Alternatively, discuss with existing shareholders to inject funds or convert debt to equity.

• Regular Financial Monitoring:

  • Implement monthly financial health checks focusing on liquidity ratios and working capital.
  • Engage accountants or financial advisors to support turnaround strategies.

• Board and Management Actions:

  • Since the director resigned recently, ensure active management oversight and proper governance to implement recovery plans.

---